Cargando…
Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France
INTRODUCTION: Because patients and patient organizations want to strengthen their role in the care pathway and drug evaluation and in order to improve pharmacovigilance activities, European competent authorities implemented regulations to allow direct reporting of adverse drug reactions related to m...
Autores principales: | Adopo, D., Daynes, P., Benkebil, M., Debs, A., Jonville-Berra, AP., Polard, E., Micallef, J., Maison, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744045/ https://www.ncbi.nlm.nih.gov/pubmed/36508012 http://dx.doi.org/10.1007/s00228-022-03422-y |
Ejemplares similares
-
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021) -
French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020) -
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023) -
COVID-19 vaccines surveillance in France: a global response to a major national challenge
por: Benkebil, Mehdi, et al.
Publicado: (2021) -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
por: Martin, Guillaume L., et al.
Publicado: (2022)